{"id":"W2176736150","doi":"10.1016/j.bbmt.2015.10.005","title":"Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors","year":2015,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute; H. Lundbeck A/S; Juno Therapeutics; Incyte; CTI Biopharma; Agios Pharmaceuticals; Novavax; Karyopharm Therapeutics; MorphoSys; Celgene; Alexion Pharmaceuticals; Amgen; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Gilead Sciences; Sanofi; Spectrum Pharmaceuticals; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ruxolitinib; Myelofibrosis; Internal medicine; Adverse effect; Transplantation; International Prognostic Scoring System; Cytopenia; Hematopoietic stem cell transplantation; Gastroenterology; Calcineurin; Confidence interval; Oncology; Bone marrow; Myelodysplastic syndromes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005059374,0.0001954565,0.0003237651,0.0003752121,0.0003576349,0.0004874364,0.0001895234,0.0003048809,0.0005972366],"category_scores_gemma":[0.001567113,0.0001656029,0.0003931119,0.0004069064,0.000275789,0.0003131614,0.0003998137,0.0004505543,0.0001061719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003225484,"about_ca_system_score_gemma":0.0003201774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00104585,"about_ca_topic_score_gemma":0.001613218,"domain_scores_codex":[0.9996959,0.00009415368,0.00003518397,0.0000527265,0.00005099328,0.00007103047],"domain_scores_gemma":[0.9989573,0.0001547974,0.0004987151,0.00005957643,0.00005611722,0.000273551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004995603,0.0000663137,0.9962987,0.000006194916,0.000062871,0.0004252378,0.00004703677,0.0001618964,0.0003413267,0.0000211493,0.0001107336,0.001959067],"study_design_scores_gemma":[0.00005609002,0.000621189,0.9962446,0.0000104653,0.00006775304,0.001840534,0.0001269377,0.0005301497,0.0001885486,0.00006415261,0.0002422815,0.000007244795],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9996406,0.0001387047,0.00002735415,0.00002624644,0.000003571621,0.000002833096,0.00004586186,9.137138e-7,0.0001138981],"genre_scores_gemma":[0.9997066,0.00005757981,0.00001642211,0.00001981964,0.00001612606,0.000003923381,0.000145878,5.880979e-7,0.00003307187],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00104585,"threshold_uncertainty_score":0.002675712,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008503955860677247,"score_gpt":0.2224208301226908,"score_spread":0.2139168742620136,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}